Trabectedin, a drug acting on both cancer cells and the tumour microenvironment

por D'Incalci, M, Badri, N, Galmarini, C M, Allavena, P
Publicado 2014

Engagement of the Mannose Receptor by Tumoral Mucins Activates an Immune Suppressive Phenotype in Human Tumor-Associated Macrophages

por Allavena, P., Chieppa, M., Bianchi, G., Solinas, G., Fabbri, M., Laskarin, G., Mantovani, A.
Publicado 2010

COVID-19 epidemic strongly affected cancer research in Italy: a survey of the Italian Cancer Society (SIC)

por Bianchi, F., Dama, E., Di Nicolantonio, F., Baldassarre, G., Guerriero, I., Torchiaro, E., Bruno, A., Blandino, G., Allavena, P., Chiarugi, P., Sozzi, G., D’Incalci, M., Normanno, N.
Publicado 2021

Corrigendum to ‘COVID-19 epidemic strongly affected cancer research in Italy: a survey of the Italian Cancer Society (SIC)’ [ESMO Open Volume 6, Issue 3, June 2021, 100165]

por Bianchi, F., Dama, E., Di Nicolantonio, F., Baldassarre, G., Guerriero, I., Torchiaro, E., Bruno, A., Blandino, G., Allavena, P., Chiarugi, P., Sozzi, G., D’Incalci, M., Normanno, N.
Publicado 2021

FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis

por Chattaragada, M S, Riganti, C, Sassoe, M, Principe, M, Santamorena, M M, Roux, C, Curcio, C, Evangelista, A, Allavena, P, Salvia, R, Rusev, B, Scarpa, A, Cappello, P, Novelli, F
Publicado 2018

Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis

por Celesti, G, Di Caro, G, Bianchi, P, Grizzi, F, Marchesi, F, Basso, G, Rahal, D, Delconte, G, Catalano, M, Cappello, P, Roncalli, M, Zerbi, A, Montorsi, M, Novelli, F, Mantovani, A, Allavena, P, Malesci, A, Laghi, L
Publicado 2013